Sign up to our newsletter Subscribe
Challenges and Solutions for Budget Impact Analysis of Gene Therapies

In this white paper, OHE presents an analysis of the relative merits and shortfalls of current approaches to defining, estimating and applying Cost-Effectiveness Thresholds (CETs) in Health Technology Assessments (HTAs). The paper also puts forward a number of policy recommendations to help guide decision makers in ensuring CETs are used to achieve improved health outcomes in the future.
Are Cost-Effectiveness Thresholds fit for Purpose for Real-World Decision Making?